Ireland
--:--IST
Recruiting Observational

TIPS in Patients With Decompensated Liver Cirrhosis

NCT04801290 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2019-08-29
Last updated
2025-09-16

Condition(s) studied

Decompensated Liver Cirrhosis

Investigational drug(s) / intervention(s)

TIPS insertion

TIPS insertion: Patients are included in the registry if they receive a transjugular intrahepatic portosystemic shunt at Hannover Medical School and provide written informed consent.

Study summary

This is a single center patient registry of patients receiving a transjugular intrahepatic portosystemic shunt (TIPS) at Hannover Medical School. By collecting and analyzing clinical data as well as blood samples, the overall aim is to optimize TIPS therapy (e.g. specify selection criteria).

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Liver cirrhosis * Indication for TIPS insertion * Treatment at the Department of Gastroenterology, Hepatology and Endocrinology of Hannover Medical School * Informed consent Exclusion Criteria: * Pregnancy or Lactation * Age \<18 years * Lack of Informed consent * Symptomatic anemia with Hb \<7g/dl

Primary outcome measure(s)

  • Mortality — 1 year
    Patients who die within 1 year
  • Occurrence of (Minimal) Hepatic Encephalopathy — 1 year
    Using the Portosystemic encephalopathy (PSE) syndrome test, critical flicker frequency (CFF) and animal naming test (S-ANT)
  • Change in Nutritional Status — 1 year
    Nutritional Status will be measured by hand grip strength (dynamometer) in kg
  • Change in Quality of Life — 1 year
    Using the questionnaire short-form 36 (SF36) (Score range 0-100, higher scores correspond to better quality of life)

Trial sites (1)

FacilityCityRegionStatus
Hannover Medical School Hanover Lower Saxony Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04801290 on ClinicalTrials.gov ↗ ← All trials in Germany